Tech Company Financing Transactions
adsilico Funding Round
adsilico closed a $13 million Series A funding round on 10/26/2026. Investors included PXN Ventures, Northern Gritstone and ParkWalk Advisors.
Transaction Overview
Company Name
Announced On
10/26/2026
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to extend its work on heart models into devices for the brain (such as flow diverters used to treat brain aneurysms) and grow its team from 14 to 34 people.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Nexus, Discovery Way
Leeds, West Yorkshire, LS2 3AA
UK
Leeds, West Yorkshire, LS2 3AA
UK
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
adsilico is a medical technology company that provides in silico (computational) insights for implantable medical devices by utilizing virtual patient populations. Founded in 2024 as a spin-out built on over 15 years of academic research, the company is based in the UK and focuses on making device testing safer, faster, and more equitable.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Chris Richardson
Chief Executive Officer
Sheena Macpherson
Chief Financial Officer
Beckie Bown
Co-Founder
Nishant Ravikumar
Co-Founder
Zeike Taylor
VP - Product Management
Anthony Holmes
Browse more venture capital transactions:
Prev: 10/26/2026: Hexagon Bio venture capital transaction
Next: 10/26/2026: DropGenie venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs